FDA Adverse Event Malfunction Summary report: N

ELECSYS DHEA-S

MDR report key: 19289035 · Received May 10, 2024

Report

Report Number
1823260-2024-01414
Event Type
Malfunction
Date Received
May 10, 2024
Date of Event
April 17, 2024
Report Date
June 6, 2024
Manufacturer
ROCHE DIAGNOSTICS
Product Code
JKC
UDI-DI
04015630940387
PMA / PMN Number
K003174
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GR
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE SAMPLE WAS SUBMITTED FOR INVESTIGATION. UPON FURTHER INVESTIGATION OF THE PATIENT SAMPLE, AN INTERFERENCE AGAINST THE STREPTAVIDIN COMPONENT OF THE REAGENT WAS CONFIRMED. PRODUCT LABELING STATES: "IN RARE CASES, INTERFERENCE DUE TO EXTREMELY HIGH TITERS OF ANTIBODIES TO ANALYTE-SPECIFIC ANTIBODIES, STREPTAVIDIN OR RUTHENIUM CAN OCCUR. THESE EFFECTS ARE MINIMIZED BY SUITABLE TEST DESIGN." THE INVESTIGATION DID NOT IDENTIFY A PRODUCT PROBLEM.

Additional Manufacturer Narrative · 0

THE E801 ANALYZER SERIAL NUMBER WAS (B)(4). THE COMPETITOR METHOD WAS ABBOTT. THE SAMPLE WAS REQUESTED FOR INVESTIGATION.

Description of Event or Problem · 0

THE INITIAL REPORTER COMPLAINED OF DISCREPANT HIGH RESULTS FOR 1 PATIENT SAMPLE TESTED FOR ELECSYS DHEA-S (DHEA-S) ON A COBAS E 801 ANALYTICAL UNIT COMPARED TO A COMPETITOR METHOD. THE INITIAL RESULT FROM THE E801 ANALYZER WAS > 1000 UG/DL. THE SAMPLE WAS SENT TO TWO EXTERNAL LABORATORIES USING THE SAME COMPETITOR METHOD AND THE RESULTS WERE APPROXIMATELY 230 UG/DL. THE REPEAT RESULT ON THE E801 ANALYZER WAS > 1000 UG/DL. ON 25-APR-2024 THE SAMPLE WAS REPEATED ON THE E801 ANALYZER AND THE RESULT WAS > 1000 UG/DL WITH A DATA FLAG.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2519202 ELECSYS DHEA-S DEHYDROEPIANDROSTERONE TEST SYSTEM JKC ROCHE DIAGNOSTICS 75160903 04015630940387

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown